Putative mechanisms of environmental chemical-induced steatosis

International Journal of Toxicology

Volumn 31, Issue 6, 2012, Pages 551-563

  Kaiser, J Phillip ^a   Lipscomb, John C ^a   Wesselkamper, Scott C ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

chlorination; liver disease; mechanism; mitochondrial impairment; steatosis

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 1,1,1,2 TETRACHLOROETHANE; ACRYLIC ACID; ALACHLOR; ALCOHOL; AMETRYN; AROCLOR 1254; BROMODICHLOROMETHANE; CARBON TETRACHLORIDE; CHLORDANE; CHLORDECONE; CHLOROFORM; ETHYLENE GLYCOL; FLURPRIMIDOL; INTERLEUKIN 1; INTERLEUKIN 6; MIREX; QUINOLINE; TOXIC SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; VINYL CHLORIDE;

ARTICLE; CHLORINATION; CYTOKINE PRODUCTION; DISEASE COURSE; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FATTY ACID OXIDATION; FATTY LIVER; GOVERNMENT; HISTOPATHOLOGY; HUMAN; INSULIN RESISTANCE; LIPID LIVER LEVEL; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER MITOCHONDRION; LIVER TOXICITY; MITOCHONDRIAL TOXICITY; NONHUMAN; PATHOGENESIS; RISK ASSESSMENT; SENSITIZATION;

ANIMALS; CARBON TETRACHLORIDE; CYTOKINES; DATABASES, FACTUAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FATTY LIVER; FEMALE; HEPATOCYTES; HYDROCARBONS, CHLORINATED; INSULIN RESISTANCE; LIPIDS; LIVER CIRRHOSIS; MALE; MICE; MITOCHONDRIA, LIVER; RATS; RISK ASSESSMENT; VINYL CHLORIDE; XENOBIOTICS;

EID: 84872079526     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581812466418     Document Type: Article

References (94)

1. Cave M, Deaciuc I, Mendez C, et al. Nonalcoholic fatty liver disease: Predisposing factors and the role of nutrition. J Nutr Biochem. 2007 ; 18 (3). 184-195
2. Donato MT, Martinez-Romero A, Jimenez N, et al. Cytometric analysis for drug-induced steatosis in HepG2 cells. Chem Biol Interact. 2009 ; 181 (3). 417-423
3. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party?. Hepatology. 1998 ; 27 (6). 1463-1466
4. Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin Liver Dis. 2004 ; 8 (3). 639-671
5. Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis. 2001 ; 21 (1). 89-104
6. Chariot P, Drogou I, de Lacroix-Szmania I, et al. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J Hepatol. 1999 ; 30 (1). 156-160
7. Letteron P, Sutton A, Mansouri A, Fromenty B, Pessayre D. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology. 2003 ; 38 (1). 133-140
8. Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006 ; 87 (1). 1-16
9. Roden M. Mechanisms of disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab. 2006 ; 2 (6). 335-348
10. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology. 2003 ; 124 (3). 778-790
11. Lelbach WK.. [Liver damage in chronic alcoholism. Results of a clinical, clinical-chemical and bioptic-histological study in 526 alcoholic patients during a low-calorie diet in an open drinking sanatorium]. Acta Hepatosplenol. 1966 ; 13 (6). 321-349
12. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003 ; 37 (4). 917-923
13. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002 ; 36 (5 suppl 1). S21 - S29
14. Cave M, Falkner KC, Ray M, et al. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology. 2010 ; 51 (2). 474-481
15. Cotrim HP, De Freitas LA, Freitas C, et al. Clinical and histopathological features of NASH in workers exposed to chemicals with or without associated metabolic conditions. Liver Int. 2004 ; 24 (2). 131-135
16. Hsiao TJ, Wang JD, Yang PM, Yang PC, Cheng TJ. Liver fibrosis in asymptomatic polyvinyl chloride workers. J Occup Environ Med. 2004 ; 46 (9). 962-966
17. Maroni M, Fanetti AC. Liver function assessment in workers exposed to vinyl chloride. Int Arch Occup Environ Health. 2006 ; 79 (1). 57-65
18. Maroni M, Mocci F, Visentin S, Preti G, Fanetti AC. Periportal fibrosis and other liver ultrasonography findings in vinyl chloride workers. Occup Environ Med. 2003 ; 60 (1). 60-65
19. Test No. 429: Skin Sensitisation, Local Lymph Node Assay. OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects. 2010 ;:
20. Larson PS, Egle JL, Hennigar GR, Lane RW, Borzelleca JF. Acute, subchronic, and chronic toxicity of chlordecone. Toxicol Appl Pharmacol. 1979 ; 48 (1 pt 1). 29-41
21. NTP (National Toxicology Program). Toxicology and Carcinogenesis Studies of Mirex (1,1a,2,2,3,3a,4,5,5,5a,5b,6-Dodecachlorooctahydro-1,3,4- metheno-1H-cyclouta[cd]pentalene) (CAS No. 2385-85-5) in F344/N Rats (Feed Studies). Vol NTP TR 313. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 1990:1-140.
22. Sokal JA, Baranski B, Majka J, et al. Experimental studies on the chronic toxic effects of vinyl chloride in rats. J Hyg Epidemiol Microbiol Immunol. 1980 ; 24 (3). 285-294
23. Khasawinah AM, Grutsch JF. Chlordane: 24-month tumorigenicity and chronic toxicity test in mice. Regul Toxicol Pharmacol. 1989 ; 10 (3). 244-254
24. Nagano K, Sasaki T, Umeda Y, et al. Inhalation carcinogenicity and chronic toxicity of carbon tetrachloride in rats and mice. Inhal Toxicol. 2007 ; 19 (13). 1089-1103
25. Kimbrough RD, Linder RE, Gaines TB. Morphological changes in livers of rats fed polychlorinated biphenyls: light microscopy and ultrastructure. Arch Environ Health. 1972 ; 25 (5). 354-364
26. Flurprimidol (Cutless) - EPA Pesticide Fact Sheet 2/89. Washington, DC: U.S. Environmental Protection Agency ; 1989 :
27. Heywood R, Sortwell RJ, Noel PR, et al. Safety evaluation of toothpaste containing chloroform. III. Long-term study in beagle dogs. J Environ Pathol Toxicol. 1979 ; 2 (3). 835-851
28. Quast JF, Humiston CG, Wade CE, et al. A chronic toxicity and oncogenicity study in rats and subchronic toxicity study in dogs on ingested vinylidene chloride. Fundam Appl Toxicol. 1983 ; 3 (1). 55-62
29. Hirao K, Shinohara Y, Tsuda H, Fukushima S, Takahashi M. Carcinogenic activity of quinoline on rat liver. Cancer Res. 1976 ; 36 (2 pt 1). 329
30. NTP (National Toxicology Program). Toxicology and Carcinogenesis Studies of Bromodichloromethane (CAS No. 75-27-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Vol NTP TR 321. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 1987:1-182.
31. Hellwig J, Deckardt K, Freisberg KO. Subchronic and chronic studies of the effects of oral administration of acrylic acid to rats. Food Chem Toxicol. 1993 ; 31 (1). 1-18
32. Ametryn. Washington, DC: ; 1961: 20460.
33. NTP (National Toxicology Program). Carcinogenesis Studies of 1,1,1,2-Tetrachloroethane (CAS: 630-20-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Vol NTP TR 237. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 1983:1-146.
34. DePass LR, Garman RH, Woodside MD, Giddens WE, Maronpot RR, Weil CS. Chronic toxicity and oncogenicity studies of ethylene glycol in rats and mice. Fundam Appl Toxicol. 1986 ; 7 (4). 547-565
35. Toxicological Review of Vinyl Chloride. Washington, DC: Office of Research and Development ;
36. Toxicological Review of Carbon Tetrachloride. Washington, DC: Office of Research and Development ;
37. Clewell HJ, Covington TR, Crump KS, Haber LT, Anderson ME The Application of A Physiologically-based Pharmacokinetic Model for Vinyl Chloride in a Noncancer Risk Assessment. Research Triangle Park, NC: National Center for Environmental Assessment ; 1995 :
38. Thrall K. D.. MEVRA. Comparative Metabolism of Carbon Tetrachloride in Rats, Mice, and Hamsters Using Gas Uptake and Pbpk Modeling. J Toxicol Environ Health A. 2000 ; 60 (8). 531-548
39. Glasgow JF, Middleton B, Moore R, Gray A, Hill J. The mechanism of inhibition of beta-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls. Biochim Biophys Acta. 1999 ; 1454 (1). 115-125
40. Mehendale HM. Chlordecone-induced hepatic dysfunction. J Toxicol Environ Health. 1981 ; 8 (5-6). 743-755
41. Desaiah D, Ho IK, Mehendale HM. Effects of kepone and mirex on mitochondrial Mg2+-ATPase activity in rat liver. Toxicol Appl Pharmacol. 1977 ; 39 (2). 219-228
42. Ogata M, Izushi F, Eto K, Sakai R, Inoue B, Noguchi N. Effect of chlordane on hepatic mitochondrial respiration. Toxicol Lett. 1989 ; 48 (1). 67-74
43. Ogata M, Hasegawa T. Effects of chlorinated aliphatic hydrocarbons on mitochondrial oxidative phosphorylation in the rat with reference to the effects of chlorinated aromatic hydrocarbons. Ind Health. 1981 ; 19 (2). 71-75
44. Aly HA, Domenech O. Aroclor 1254 induced cytotoxicity and mitochondrial dysfunction in isolated rat hepatocytes. Toxicology. 2009 ; 262 (3). 175-183
45. Martin EJ, Racz WJ, Forkert PG. Mitochondrial dysfunction is an early manifestation of 1,1-dichloroethylene-induced hepatotoxicity in mice. J Pharmacol Exp Ther. 2003 ; 304 (1). 121-129
46. Mitchell C, Robin MA, Mayeuf A, et al. Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice. Am J Pathol. 2009 ; 175 (5). 1929-1937
47. Lock T, Cottrell L, Soames T, Jacobsen M, Williams R. Formic acid excretion in rats and mice exposed to bromodichloromethane: a possible link to renal tubule cell proliferation in long-term studies. Arch Toxicol. 2004 ; 78 (7). 410-417
48. Song C, Scharf ME. Mitochondrial impacts of insecticidal formate esters in insecticide-resistant and insecticide-susceptible Drosophila melanogaster. Pest Manag Sci. 2009 ; 65 (6). 697-703
49. McMartin KE, Wallace KB. Calcium oxalate monohydrate, a metabolite of ethylene glycol, is toxic for rat renal mitochondrial function. Toxicol Sci. 2005 ; 84 (1). 195-200
50. Bowyer JR, Crofts AR. On the mechanism of photosynthetic electron transfer in Rhodopseudomonas capsulata and Rhodopseudomonas sphaeroides. Biochim Biophys Acta. 1981 ; 636 (2). 218-233
51. Bai S, Chaney W. Gibberellin synthesis inhibitors affect electron transport in plant mitochondria. Plant Growth Regulation. 2001 ; 35 (3). 257-262
52. Kawai K, Shiojiri H, Watanabe R, Nozawa Y.. Chlorination-induced enhancement of biological activities in imidazole antimycotics. A possible explanation to the molecular mechanism for their antimycotic activities. Res Commun Chem Pathol Pharmacol. 1983 ; 40 (2). 255-265
53. Whiteman M, Spencer JP, Szeto HH, Armstrong JS. Do mitochondriotropic antioxidants prevent chlorinative stress-induced mitochondrial and cellular injury?. Antioxid Redox Signal. 2008 ; 10 (3). 641-650
54. Cave M, Appana S, Patel M, Falkner KC, McClain CJ, Brock G.. Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. Environ Health Perspect. 2010 ; 118 (12). 1735-1742
55. Bowman BJ, Mainzer SE, Allen KE, Slayman CW. Effects of inhibitors on the plasma membrane and mitochondrial adenosine triphosphatases of Neurospora crassa. Biochim Biophys Acta. 1978 ; 512 (1). 13-28
56. Reynolds ES, Moslen MT. Damage to hepatic cellular membranes by chlorinated olefins with emphasis on synergism and antagonism. Environ Health Perspect. 1977 ; 21: 137-147
57. Reynolds ES, Moslen MT, Szabo S, Jaeger RJ, Murphy SD. Hepatotoxicity of vinyl chloride and 1,1-dichloroethylene. Role of mixed function oxidase system. Am J Pathol. 1975 ; 81 (1). 219-236
58. Lieber CS. Hepatic, metabolic, and nutritional disorders of alcoholism: from pathogenesis to therapy. Crit Rev Clin Lab Sci. 2000 ; 37 (6). 551-584
59. Hefner RE, Watanabe PG, Gehring PJ. Preliminary studies on the fate of inhaled vinyl chloride monomer (VCM) in rats. Environ Health Persp. 1975 ; 11: 85-95
60. Kraut JA, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 2008 ; 3 (1). 208-225
61. Lubet RA, Jones CR, Stockus DL, Fox SD, Nims RW. Induction of cytochrome P450 and other drug metabolizing enzymes in rat liver following dietary exposure to Aroclor 1254. Toxicol Appl Pharmacol. 1991 ; 108 (2). 355-365
62. Thijsse GJ. Fatty-acid accumulation by acrylate inhibition of beta-oxidation in alkane-oxidizing pseudomonas. Biochim Biophys Acta. 1964 ; 84: 195-197
63. Nandi A, Kitamura Y, Kahn CR, Accili D. Mouse models of insulin resistance. Physiol Rev. 2004 ; 84 (2). 623-647
64. Wang L, Balas B, Christ-Roberts CY, et al. Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo. Mol Cell Biol. 2007 ; 27 (18). 6497-6505
65. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004 ; 114 (2). 147-152
66. Han S, Liang CP, Westerterp M, et al. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J Clin Invest. 2009 ; 119 (4). 1029-1041
67. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004 ; 89 (6). 2548-2556
68. Meyer-Alber A, Hartmann H, Stumpel F, Creutzfeldt W. Mechanism of insulin resistance in CCl4-induced cirrhosis of rats. Gastroenterology. 1992 ; 102 (1). 223-229
69. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010 ; 7 (5). 251-264
70. Venkatesan S, Ward RJ, Peters TJ. Effect of chronic ethanol feeding on the hepatic secretion of very-low-density lipoproteins. Biochim Biophys Acta. 1988 ; 960 (1). 61-66
71. Mendoza-Figueroa T, Hernandez A, Lopez ML. Triglyceride accumulation in long-term cultures of adult rat hepatocytes by chronic exposure to Aroclor 1254. J Toxicol Environ Health. 1989 ; 26 (3). 293-308
72. Lombardi B, Ugazio G. Serum lipoproteins in rats with carbon tetrachloride-induced fatty liver. J Lipid Res. 1965 ; 6 (4). 498-505
73. Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest. 1987 ; 80 (1). 184-190
74. Hardardottir I, Doerrler W, Feingold KR, Grunfeld C. Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism. Biochem Biophys Res Commun. 1992 ; 186 (1). 237-243
75. Nachiappan V, Curtiss D, Corkey BE, Kilpatrick L. Cytokines inhibit fatty acid oxidation in isolated rat hepatocytes: synergy among TNF, IL-6, and IL-1. Shock. 1994 ; 1 (2). 123-129
76. Yin M, Wheeler MD, Kono H, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology. 1999 ; 117 (4). 942-952
77. Malarkey DE, Johnson K, Ryan L, Boorman G, Maronpot RR. New insights into functional aspects of liver morphology. Toxicol Pathol. 2005 ; 33 (1). 27-34
78. Hong CC, Shimomura-Shimizu M, Muroi M, Tanamoto K. Effect of endocrine disrupting chemicals on lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by mouse macrophages. Biol Pharm Bull. 2004 ; 27 (7). 1136-1139
79. Lynn AD, Kyriakides TR, Bryant SJ. Characterization of the in vitro macrophage response and in vivo host response to poly(ethylene glycol)-based hydrogels. J Biomed Mater Res A. 2010 ; 93 (3). 941-953
80. Navasa M, Gordon DA, Hariharan N, et al. Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines. J Lipid Res. 1998 ; 39 (6). 1220-1230
81. Liu C, Tao Q, Sun M, et al. Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats. Lab Invest. 2010 ; 90 (12). 1805-1816
82. Wang F, Sobel ES, Butfiloski EJ, Roberts SM. Comparison of chlordecone and estradiol effects on splenic T-cells in (NZBxNZW)F(1) mice. Toxicol Lett. 2008 ; 183 (1-3). 1-9
83. Ban M, Hettich D, Goutet M, Binet S. Serum-borne factor(s) of 1,1-dichloroethylene and 1,2-dichlorobenzene-treated mice inhibited in vitro antibody forming cell response and natural killer cell activity. Toxicol Lett. 1998 ; 94 (2). 93-101
84. Ward JR, West PW, Ariaans MP, et al. Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms. J Biol Chem. 2010 ; 285 (30). 23147-23158
85. Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 2003 ; 33 (2). 105-136
86. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995 ; 95 (5). 2409-2415
87. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W.. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem. 1992 ; 267 (8). 5317-5323
88. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A. 1997 ; 94 (6). 2557-2562
89. Platonow NS, Karstad LH. Dietary effects of polychlorinated biphenyls on mink. Can J Comp Med. 1973 ; 37 (4). 391-400
90. Yamaguchi K, Yang L, McCall S, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007 ; 45 (6). 1366-1374
91. Beier JI, Luyendyk JP, Guo L, von Montfort C, Staunton DE, Arteel GE. Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice. Hepatology. 2009 ; 49 (5). 1545-1553
92. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis. 2004 ; 8 (3). 521-533
93. Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol. 2011 ; 17 (26). 3082-3091
94. Day CP. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med. 2006 ; 6 (1). 19-25